[3분기 실적발표] 2024년 3분기 실적발표 자료입니다 (국문) — ST PHARM

Science & Technology
- Business Overview사업영역
- CDMO위탁생산개발
- CRO위탁임상서비스
  - AnaPath Research & Service
- R&D연구개발
  - Virtual R&D
  - Global R&D
About
Public
- PR (Public Relations)
  - News room
- IR (Investor Relations)
  - Stock Information
  - IR Library
Careers
ESG

Linkedin

Public

IR Materials

PR (Public Relations)
- News room
IR (Investor Relations)
- Stock Information
- IR Library

IR Materials

Nov 1, 2024

[3분기 실적발표] 2024년 3분기 실적발표 자료입니다 (국문)

「반출」에스티팜_실적발표_24.3Q.pdf